RYUKAKUSAN CO., LTD. – Trademark Portfolio
Entity Type: 03
RYUKAKUSAN CO., LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include RYUKAKUSAN and RYUKAKU-SAN. The owner is based in Chiyoda-ku, Tokyo.
5-12, Hihgashi-Kanda 2-chome
Chiyoda-ku, Tokyo 101-0031 , JP
Showing of trademarks Trademarks
Trademark Classifications
RYUKAKUSAN CO., LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does RYUKAKUSAN CO., LTD. have?
RYUKAKUSAN CO., LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 1 cancelled.
What trademark classes does RYUKAKUSAN CO., LTD. file in?
RYUKAKUSAN CO., LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are RYUKAKUSAN CO., LTD.'s most well-known trademarks?
RYUKAKUSAN CO., LTD.'s registered trademark portfolio includes well-known marks such as RYUKAKUSAN and RYUKAKU-SAN. These are among 5 currently registered trademarks in the portfolio.
What is RYUKAKUSAN CO., LTD.'s trademark registration success rate?
RYUKAKUSAN CO., LTD. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.